Growth Metrics

Penumbra (PEN) Cash from Investing Activities Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Penumbra 12.52 Bn 11.91 Bn 253.41 Mn -6,002.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6,002.19%
Dec 31, 2025 -1,959.76%
Sep 30, 2025 -555.93%
Jun 30, 2025 -145.19%
Mar 31, 2025 -102.73%
Dec 31, 2024 -145.12%
Sep 30, 2024 180.46%
Jun 30, 2024 616.77%
Mar 31, 2024 71.64%
Dec 31, 2023 181.25%
Sep 30, 2023 -553.67%
Jun 30, 2023 -132.29%
Mar 31, 2023 -31.82%
Dec 31, 2022 744.73%
Sep 30, 2022 119.64%
Jun 30, 2022 -21.58%
Mar 31, 2022 408.45%
Dec 31, 2021 86.91%
Sep 30, 2021 -0.84%
Jun 30, 2021 148.30%
Mar 31, 2021 -69.21%
Dec 31, 2020 76.62%
Sep 30, 2020 -446.03%
Jun 30, 2020 -260.91%
Mar 31, 2020 -68.49%
Dec 31, 2019 -554.38%
Sep 30, 2019 169.17%
Jun 30, 2019 -217.85%
Mar 31, 2019 1,556.56%
Dec 31, 2018 158.71%
Sep 30, 2018 13.32%
Jun 30, 2018 146.69%
Mar 31, 2018 78.08%
Dec 31, 2017 -489.68%
Sep 30, 2017 -522.88%
Jun 30, 2017 -2,012.62%
Mar 31, 2017 -721.95%
Dec 31, 2016 103.25%
Sep 30, 2016 -166.67%
Jun 30, 2016 -103.47%
Mar 31, 2016 -78.73%
Dec 31, 2015 -15,671.60%